Cell Culture Market Size To Hit USD 63.60 Billion By 2032

The global cell culture market size was valued at USD 26.54 billion in 2023 and is projected to hit around USD 63.60 billion by 2032 with a registered CAGR of 10.20% from 2023 to 2032.

Key Points

By consumable, the media segment has market share of around 51% in 2022.
By product, the culture systems segment has accounted for 26% of the market share in 2022.
By application, the biopharmaceuticals segment has captured highest makret share of around 27% in 2022.
By region, the North America has contributed market share of around 42% in 2022.

The surging awareness regarding the benefits of cell based vaccines, rising prevalence of cancer and other diseases, growing demand for monoclonal antibodies, increasing investments in the cell based research studies, rising focus towards personalized medicines, growing adoption of single use technologies, and rising technological advancements in the cell culture techniques are some of the major factors that are expected to boost the growth of the global cell culture market.

Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1803

As per the International Agency for Research on Cancer, in 2020, there were around 10 million deaths and 19.3 million new cases of cancer recorded across the globe. The rising prevalence of cancer is significantly boosting the demand for the monoclonal antibodies for the treatment and hence, the demand for the cell culture is bolstering.

Moreover, the rapid emergence and rapidly growing adoption of the 3D cell culture techniques is further fueling the growth of the global cell culture market. The rising investments towards the development of cell based vaccines and drugs is expected to drive the global market during the forecast period. Moreover, the various developmental strategies such as new product launches, mergers, and acquisitions are expected to significantly contribute towards the market growth in the forthcoming future.

Report Highlights

Based on product, the consumables segment dominated the market. The extensive usage of consumables in the research activities and the presence of huge number of research institutes, biopharmaceutical companies, and numerous contract manufacturing and contract research organizations has led to the extensive demand for the consumables across the globe.
Based on the application, the drug discovery is expected to be the fastest-growing segment. The rising prevalence of various chronic and gene related diseases has fueled the demand for the innovative therapies and vaccines to effectively treat the diseases. The biopharma companies are extensively investing in the drug discovery and development activities to develop new and effective therapies.

Regional Snapshot

North America was the leading cell culture market in 2021. The outbreak of COVID-19 diseases and its rapid spread across the globe has attracted huge investments in the research studies that exponentially contributed to the growth of the cell culture market. Moreover, the North America region is the home to several top biopharmaceutical companies and several contract manufacturing and research organizations that spurs the demand for the cell culture techniques exponentially. The various government policies in US supports the medical research activities as the healthcare is one of the major industries in US. Healthcare expenditure accounted for around 18% of the US GDP in 2018.In 2016, The Human Cancer Models Initiative was undertaken to grow 1,000 new cell line for scientific studies within a period of three years. The favorable government support in medical research studies has significantly fostered the growth of the North America cell culture market.

Asia Pacific is estimated to be the most opportunistic market during the forecast period. The presence of several top research institutes and contract research organizations significantly boosts the demand for the cell culture consumables. The rising demand for the development of various new and innovative drugs and vaccines is bolstering the growth of the Asia Pacific cell culture market.

Table of Contents

Report Scope of the Cell Culture Market

Report Coverage	Details
Market Size by 2032	USD 63.60 Billion
Growth Rate from 2023 to 2032	CAGR of 10.20%
Largest Market	North America
Fastest Growing Region	Asia Pacific
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	Type, Application, End User, Distribution Channels, Geography

Cell Culture Market Dynamics

Driver

Surging awareness regarding the advantages of cell-based vaccines

Climate change, rising global population, and rising contact between animals and human has increased the risks of outbreaks of new viruses. Influenza, Swine Flu, and COVID-19 are some examples. This is a major factor that is boosting the need for cell based medical research studies to develop cell based vaccines to treat the various viruses and infections. Previously, the cell culture techniques has helped in the development of vaccines for various diseases such as smallpox, polio, rotavirus, hepatitis, and chickenpox. Therefore, the rising awareness regarding the benefits of cell based vaccines is expected to drive the growth of the cell culture market.

Restraint

High costs involved in cell biology research

The cell biology involves research and development on new therapies like gene therapies and stem cell therapies. A high capital investment is required in the acquisition of various equipment and consumables that facilitates cell based biology research. Moreover, maintaining quality of the research studies and compliances to the regulatory guidelines has fueled the costs involved. Thus the high costs is a major restraining factor in the cell culture market.

Opportunity

Surging demand for the 3D cell culture

The various advantages of the 3D cell culture over the 2D cell culture is boosting the demand for the 3D cell culture techniques. The greater stability and extended life spans of the 3D cell cultures over the 2D counterpart has boosted the adoption of the 3D cell culture across the globe. The rising adoption of the 3D cell culture is expected to drive the market growth in the foreseeable future.

Challenge

Generation of plastic wastes

The extensive usage of the plastic consumables in the cell based research activities generates a huge volume of plastic wastes. Plastics are non-biodegradable are have a negative impact on the environment. The disposal of the plastic wastes has emerged as a major challenge for the market players.

Key Market Developments

In October 2019, Thermo Fisher Scientific introduced the first cell culture media that remain stable at room temperature.
In October 2021, Thermo Fischer Scientific introduced its Gibco Cell Therapy Systems (CTS) NK-Xpander Medium that facilitates the growth and culture of functional natural killer cells at large scale.
In September 2021, Cytiva expanded its production capacity by launching 3 manufacturing facilities in just 10 months for bio-processing single use consumables.

Some of the prominent players in the global cell culture market include:

Corning Incorporated
Merck KGaA
Sartorius AG
BioSpherix, Ltd.
Cell Culture Company, LLC
Thermo Fisher Scientific Inc.
VWR International LLC
Lonza
Eppendorf AG
FUJIFILM Irvine Scientific, Inc.

Segments Covered in the Report

By Product

Equipment
- Centrifuges
- Culture Systems/Bioreactors
- Biosafety Equipment
- Cryostorage Equipment
- Pipetting Instruments
- Incubators
- Cell Culture Vessels
- Others
Consumables
- Reagents
- Growth Factors & Cytokines
- Albumin
- Protease inhibitor
- Thrombin
- Attachment Factors
- Amino Acids
Sera
- Fetal Bovine Serum (FBS)
- Others
Media
- Chemically Defined
- Classical Media
- Lysogeny Broth
- Serum Free
- Protein Free
- Specialty Media

By Application

Drug Discovery
Biopharmaceuticals
- Monoclonal antibodies
- Vaccines production
- Other therapeutic proteins
Tissue Culture and Engineering
- Cell and gene therapy
- Other tissue engineering & regenerative medicine applications
Vaccine Production
Gene Therapy
Others

By End User

Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Other

By Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa